HK1145693A1 - Optimized dengue virus entry inhibitory peptide (dn81) - Google Patents

Optimized dengue virus entry inhibitory peptide (dn81)

Info

Publication number
HK1145693A1
HK1145693A1 HK10112269.7A HK10112269A HK1145693A1 HK 1145693 A1 HK1145693 A1 HK 1145693A1 HK 10112269 A HK10112269 A HK 10112269A HK 1145693 A1 HK1145693 A1 HK 1145693A1
Authority
HK
Hong Kong
Prior art keywords
dengue virus
inhibitory peptide
virus entry
entry inhibitory
optimized
Prior art date
Application number
HK10112269.7A
Other languages
English (en)
Inventor
Scott F Michael
Sharon Isern
Robert Garry
Ram Samudrala
Joshua Costin
Ekachai Jenwitheesuk
Original Assignee
Florida Gulf Coast University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida Gulf Coast University filed Critical Florida Gulf Coast University
Publication of HK1145693A1 publication Critical patent/HK1145693A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10112269.7A 2007-07-13 2010-12-30 Optimized dengue virus entry inhibitory peptide (dn81) HK1145693A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94971007P 2007-07-13 2007-07-13
PCT/US2008/069716 WO2009048658A2 (en) 2007-07-13 2008-07-11 Optimized dengue virus entry inhibitory peptide (dn81)

Publications (1)

Publication Number Publication Date
HK1145693A1 true HK1145693A1 (en) 2011-04-29

Family

ID=40549787

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10112269.7A HK1145693A1 (en) 2007-07-13 2010-12-30 Optimized dengue virus entry inhibitory peptide (dn81)

Country Status (11)

Country Link
US (1) US8541377B2 (xx)
EP (1) EP2178903B1 (xx)
CN (1) CN101801996B (xx)
AP (1) AP3172A (xx)
AT (1) ATE547425T1 (xx)
AU (1) AU2008311220B2 (xx)
CO (1) CO6260142A2 (xx)
DK (1) DK2178903T3 (xx)
EC (1) ECSP109947A (xx)
HK (1) HK1145693A1 (xx)
WO (1) WO2009048658A2 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3166063A1 (en) 2013-03-15 2014-09-25 Takeda Vaccines, Inc. Compositions and methods for dengue virus chimeric constructs in vaccines
CN105801674B (zh) * 2016-04-05 2019-03-12 首都医科大学 登革病毒e蛋白阻断肽p7及其应用
CN105777877B (zh) * 2016-04-05 2019-03-12 首都医科大学 登革病毒e蛋白阻断肽p4及其应用
US10639380B2 (en) * 2016-12-06 2020-05-05 Ennaid Therapeutics, LLC Flavivirus-binding, entry-obstructing, protease-resistant peptide (RI57)
EP4082568A1 (en) 2018-09-05 2022-11-02 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002501A2 (en) * 2003-04-22 2005-01-13 Children's Medical Center Corporation Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same

Also Published As

Publication number Publication date
WO2009048658A2 (en) 2009-04-16
ATE547425T1 (de) 2012-03-15
CN101801996A (zh) 2010-08-11
AU2008311220B2 (en) 2013-10-03
US20110112031A1 (en) 2011-05-12
WO2009048658A9 (en) 2009-06-11
DK2178903T3 (da) 2012-06-18
CO6260142A2 (es) 2011-03-22
AP3172A (en) 2015-03-31
AP2010005141A0 (en) 2010-02-28
ECSP109947A (es) 2010-05-31
CN101801996B (zh) 2013-06-12
EP2178903A4 (en) 2010-11-17
US8541377B2 (en) 2013-09-24
EP2178903A2 (en) 2010-04-28
AU2008311220A1 (en) 2009-04-16
EP2178903B1 (en) 2012-02-29
WO2009048658A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
IL219040A (en) Peptide compounds derived from (cadherin3 (cdh3)
EP2298801A4 (en) GLYCOSYLATED GLP-1 PEPTIDE
EP2172479A4 (en) PEPTIDE GLP-1 HAVING A SUGAR CHAIN BOUND THERETO
GB0508863D0 (en) Peptide
EP2176420A4 (en) ANTIMICROBIAL PEPTIDES DERIVED FROM VIRUSES
EP2017283A4 (en) Peptides
EP2142572A4 (en) TGFP CAP PEPTIDE AND APPLICATIONS THEREOF
HUE038953T2 (hu) Peptid szekvenciák és készítmények anopheles gambiae-fajból
EP1858914A4 (en) PEPTIDE NETWORKS
ZA201001451B (en) Immunomodulatory peptides
GB0723712D0 (en) Peptides
HK1145693A1 (en) Optimized dengue virus entry inhibitory peptide (dn81)
EP2101804A4 (en) PRO-ANGIOGENIC PEPTIDES
EP2015766A4 (en) CYCLISED ALPHA CONOTOXIN PEPTIDES
EP2123666A4 (en) PEPTIDE
HK1155762A1 (en) Highly bridged peptides from actinomadura namibiensis actinomadura namibiensis
EP2036918A4 (en) PEPTIDE DERIVATIVE
GB0618748D0 (en) Peptide
EP1982728A4 (en) HEPATITIS C-VIRUS DERIVED PEPTIDE
ZA200807552B (en) Recombinant mononegaviral virus vectors
GB0703945D0 (en) Peptide
GB0605774D0 (en) Peptide
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
EP2097439A4 (en) NEW PEPTIDE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200707